跳至主要内容
临床试验/NCT00677586
NCT00677586已完成不适用

Simultaneous Versus Staged Resection for Initially Resectable Synchronous Rectal Cancer Liver-limited Metastasis: A Randomized Controlled Trial

Fudan University0 个研究点目标入组 180 人开始时间: 2010年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
180
主要终点
Severe complication rate after resection of primary and metastatic lesions

研究概览

简要总结

The purpose of this study is to investigate the safety and efficacy of simultaneous liver resections compared to staged hepatectomies of rectal cancer with liver metastasis and to compare the short and long-term survival between the two groups.

详细描述

The optimal surgical strategy for treatment of patients with resectable synchronous rectal liver metastases remains controversial. To answer whether synchronous rectal cancer liver metastases (SLM) should be resected simultaneously with primary cancer or should be delayed, We conducted a randomized, controlled trial to compare the safety and efficacy of simultaneous versus delayed resection of the rectum and liver. Patients with rectal cancer and resectable SLM were randomly assigned to either simultaneous or delayed resection of the metastases. The primary outcome was the rate of major complications (Clavien-Dindo grade≥III) within 30 days following surgery. Secondary outcomes included disease-free and overall survival. A consecutive patients of rectal cancer with liver metastasis from ZhongShan hospital, Fudan university were enrolled and randomly assigned to simultaneous liver resections and staged hepatectomies. Post-operative complications, peri-operative mortality, long-term survival were compared.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age>=18 and <= 75 years
  • resectable primary rectal tumor
  • remnant liver volume >= 60%
  • without other organ metastasis or peritoneum metastasis
  • without contradiction of cardiac and pulmonary diseases
  • American Society of Anesthesiologists (ASA) class I - II
  • Histologically proved rectal adenocarcinoma

排除标准

  • age > 75 years
  • unresectable primary rectal tumor
  • remnant liver volume < 60%
  • with other organ metastasis or peritoneum metastasis
  • with contradiction of cardiac and pulmonary diseases
  • Tumors assessed as clinical complete response after preoperative radio- or chemoradiotherapy
  • Signs of acute intestinal obstruction, bleeding or perforation needing emergency surgery
  • Multiple colorectal tumors or other schedules needing for synchronous colon surgery
  • Co-existent inflammatory bowel disease
  • Pregnancy or lactation
  • Patients received treatment other than preoperative radio- or chemoradiotherapy

结局指标

主要结局

Severe complication rate after resection of primary and metastatic lesions

时间窗: 30 days after surgery

Grade of III-V complication rate according to Clavien-Dindo

次要结局

  • Disease free survival(3 years)
  • Overall survival(3 years)
  • Postoperative hospital stay(30 days after surgery)
  • Post-operative mortality(90 days after surgery)
  • Complication rate after resection of primary and metastatic lesions(30 days after surgery)
  • Cost of hospitalization(2 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xu jianmin

Deputy director of the department of general surgery

Fudan University

相似试验